Cardiometabolic factors in a comunity located at Valencia city, Venezuela;Factores cardiometabólicos en una comunidad de Valencia, Venezuela

Revista de Salud Publica

Volumn 11, Issue 3, 2009, Pages 383-394

  Ruiz Fernández, Nelina ^a   Espinoza, Milagros ^a   Barrios, Emilia ^a   Reigosa, Aldo ^a  

^a UNIVERSIDAD DE CARABOBO   (Venezuela)

Author keywords

Abdominal fat; Cardiovascular disease; Diabetes mellitus; Hypertension; Metabolic syndrome X; NLM); Obesity; Risk factor (source: MeSH

Indexed keywords

EID: 77649131380     PISSN: 01240064     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Ministerio del Poder Popular para la Salud de la República Bolivariana de Venezuela. Anuario de Mortalidad 2006. Caracas: MPPS de Venezuela; 2007.
2. Eckel RH, Kahn R, Robertson RM, Rizza RA. Preventing Cardiovascular Disease and Diabetes: A Call to Action From the American Diabetes Association and the American Heart Association. Circulation 2006; 113:2943-2946.
3. Barnett AH- The importance of treating cardiometabolic risk factors in patients with type 2 diabetes. Diabetes Vasc Dis Res 2008; 5:9-14.
4. Grupo CONVERGE. Diagnóstico y tratamiento del riesgo cardiometabólico. Med Clin (Barc) 2007; 129(15):588-596.
5. Méndez-Castellanos H. Sociedad y Estratificación. Método Graffar-Méndez Castellano. Caracas: Fundacredesa; 1994.
6. Rodriguez-Larralde A, Mijares ME, Nagy E, Espinosa R, Ryder E, Diez-Ewald MP et al. Relación entre el nivel socioeconómico y hábitos de vida, con el fibrinógeno y el factor von willebrand en venezolanos sanos y con cardiopatía isquémica. Invest Clin 2005; 46(2): 157-168.
7. Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Champaign, IL: Human Kinetics Books; 1988.
8. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA 2003; 289(19):2560-2571.
9. World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. WHO Technical Report Series 854. Geneva: World Health Organization; 1995.
10. Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497.
11. a Edición. Barcelona, España: Masson; 2000.
12. Matthews D, Hosker J, Rudenski A, Naylor B, Teacher D, Turner R. Homeostasis model assessment insulin resistance and cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28:412-419.
13. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 2003; 26 Suppl 1:S21-24.
14. Sociedad Venezolana de Endocrinología y Metabolismo. Consenso nacional de diabetes mellitus tipo 2, Venezuela. Caracas: Traducciencia; 2003.
15. Abondano A, Alvarado A, Angulo V, García C, Marino P, Guevara H, et al. Prevalencia de hipertensión arterial en los distritos sanitarios del estado Carabobo, Venezuela. Informed 2007; 10:501-507.
16. Schargrodsky H, Hernández-Hernández R, Champagne BM, Silva H, Vinueza R, Silva Ayçaguer LC et al. CARMELA: assessment of cardiovascular risk in seven Latin American cities. Am J Med 2008; 121(1):58-65.
17. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289(18):2363-2369.
18. Florez H, Silva E, Fernández V, Ryder E, Sulbarán T, Campos G et al. Prevalence and risk factors associated with the metabolic syndrome and dyslipidemia in white, black, amerindian and mixed hispanics in Zulia State, Venezuela. Diabetes Res Clin Pract 2005; 69(1):63-77.
19. Palomo I, Icaza G, Mujica V, Núñez L, Leiva E, Vásquez M et al. Prevalencia de factores de riesgo cardiovascular clásicos en población adulta de Talca, Chile, 2005. Rev Med Chile 2007; 135(7):904-912.
20. Bautista LE, Oróstegui M, Vera LM, Prada GE, Orozco LC, Herrán OF. Prevalence and impact of cardiovascular risk factors in Bucaramanga, Colombia: results from the Countrywide Integrated Noncommunicable Disease Intervention Programme (CINDI/ CARMEN) baseline survey. Eur J Cardiovasc Prev Rehabil 2006; 13(5):769-775.
21. Hoffmann IS, Cubeddu LX. Clustering of silent cardiovascular risk factors in apparently healthy Hispanics. J Hum Hypertens 2002; 16 Suppl 1:S137-1341.
22. Barria RM, Amigo H. Transición Nutricional: Una revisión del perfil Latinoamericano. ALAN 2006; 56(1):3-11.
23. Organización Panamericana de la Salud/Organización Mundial de la Salud. Evaluación económica de políticas públicas para el control del tabaquismo en Venezuela. Caracas: OPS/OMS; 2004.
24. Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008; 28(6):1039-1049.
25. Díaz JE, Muñoz J, Sierra CH. Factores de riesgo para enfermedad cardiovascular en trabajadores de una institución prestadora de servicios de salud, Colombia. Rev. Salud Pública (Bogotá) 2007; 9(1):64-75.
26. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008; 28 (4):629-36.
27. Espinoza M, Leal U, De Freitas L, Oroño F, Acosta E, Castrillo S, et al. Prevalencia de síndrome metabólico en pacientes adultos de la población de San Diego, Valencia- Estado Carabobo. Informed 2008; 10(2):83-93.
28. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287(3):356-359.
29. Martínez MA, Puig JG, Mora M, Aragón R, O'Dogherty P, Antón JL et al. Metabolic syndrome: prevalence, associated factors, and C-reactive protein: the MADRIC (MADrid RIesgo Cardiovascular) Study. Metabolism. 2008; 57(9):1232-1240.
30. Oh EG, Bang SY, Hyun SS. Prevalence and clinical characteristics of metabolic syndrome for at-risk people in a rural community. Metab Syndr Relat Disord 2008; 6(4):248-254.
31. Hernández WI. Factores de riesgo de enfermedad cardiovascular en una población obrera industrial de la provincia de Cartago. Rev Costarric Salud Pública 2000; 9(16):55-64.
32. Pereira JC, Barreto SM, Passos VM. The profile of cardiovascular health of elderly brazilian people needs to improve: a population-based study. Arq Bras Cardiol 2008; 91(1):1-10.
33. Yusuf HR, Giles WH, Croft JB, Anda RF, Casper ML. Impact of multiple risk factor profiles on determining cardiovascular disease risk. Prev Med 1998; 27(1):1-9.
34. Mendivil CO. Obesity and metabolic syndrome. Acta Med Colomb 2005; 30(3):164-167.